Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-04-23

FDA Approved: OSPHENA — Supplemental Application (Duchesnay USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for OSPHENA (ospemifene) from Duchesnay USA, Inc. to modify the labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Osphena (ospemifene)

Snippet

SUPPL AP for OSPHENA (OSPEMIFENE)